¼¼°èÀÇ Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀå
Phosphatidylserine
»óǰÄÚµå : 1744826
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 463 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,026,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,080,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀåÀº 2030³â±îÁö 1¾ï 9,690¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 1¾ï 5,350¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀåÀº 2024-2030³â¿¡ CAGR 4.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 1¾ï 9,690¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ À°·ù °ø±Þ¿øÀº CAGR 4.1%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 2,520¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ¾î·ù °ø±Þ¿ø ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 4.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4,180¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÇÑÆí, Áß±¹Àº CAGR 7.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀåÀº 2024³â¿¡´Â 4,180¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 4,030¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 7.7%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.7%¿Í 3.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Æ÷½ºÆÄƼµô¼¼¸°ÀÌ ÀÎÁö °Ç°­ ¼ººÐÀ¸·Î ÁÖ¸ñ¹Þ´Â ÀÌÀ¯´Â?

Æ÷½ºÆÄƼµô¼¼¸°(PS)Àº ÁÖ·Î ¼¼Æ÷¸·¿¡ Á¸ÀçÇϴ õ¿¬ À¯·¡ ÀÎÁöÁú·Î, ½Å°æ¼¼Æ÷ÀÇ ¿ÏÀü¼ºÀ» À¯ÁöÇϰí ÀÎÁö±â´ÉÀ» Áö¿øÇÏ¸ç ±â¾ï·ÂÀ» Çâ»ó½ÃŰ´Â ¿ªÇÒÀÌ ÀÔÁõµÇ¾î ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¿ø·¡ ¼ÒÀÇ ³ú Á¶Á÷¿¡¼­ À¯·¡ÇÑ PS º¸ÃæÁ¦´Â ÇöÀç ´ëµÎ ·¹½Ãƾ°ú ÇØ¹Ù¶ó±â ·¹½ÃƾÀ» ÁÖ¿ø·á·Î ÇÏ´Â °ÍÀÌ ÁÖ·ù¸¦ ÀÌ·ç°í ÀÖÀ¸¸ç, ¼ÒºñÀÚ¿¡°Ô º¸´Ù ¾ÈÀüÇÑ ½Ä¹°¼º ´ëüǰÀ» Á¦°øÇÕ´Ï´Ù. ÀÎÁö±â´É ÀúÇÏ, ÁÖÀÇ·Â Àå¾Ö, ½ºÆ®·¹½º¿Í °ü·ÃµÈ ½Å°æÁõ»óÀÌ Áõ°¡ÇÏ´Â Ãß¼¼¿¡ µû¶ó PS¸¦ ÁÖ¼ººÐÀ¸·Î ÇÏ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

°úÇÐÀû ¿¬±¸¸¦ ÅëÇØ PS°¡ ±â¾ï·Â À¯Áö, ÁÖÀÇ·Â Çâ»ó, ÀÎÁö ÇÇ·Î °¨¼Ò, ƯÈ÷ ³ëÀΰú ÁÖÀÇ·Â °áÇÌ ¹®Á¦¸¦ °¡Áø »ç¶÷µéÀÇ Áõ»ó ¿ÏÈ­¿¡ È¿°ú°¡ ÀÖ´Ù´Â °ÍÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ±× °á°ú, PS´Â ³ú °Ç°­À» ¸ñÇ¥·Î ÇÏ´Â ¿µ¾ç º¸ÃæÁ¦, ÇâÁ¤½Å¼º ÀǾàǰ, ±â´É¼º ½ÄǰÀÇ Áß¿äÇÑ ±â´É¼º ¼ººÐÀ¸·Î Àα⸦ ²ø°í ÀÖÀ¸¸ç, ƯÈ÷ ³ëÀÎ, Çлý, ¿îµ¿¼±¼ö, ºñ¾à¸®ÇÐÀûÀÎ ¹æ¹ýÀ¸·Î Á¤½ÅÀÇ ¸í·á¼º, ÁýÁß·Â, ½Å°æ º¸È£¸¦ ¿øÇÏ´Â Á÷ÀåÀε鿡°Ô ÀαⰡ ÀÖ½À´Ï´Ù.

Àü´Þ ÇüÅÂ, ¼ººÐÀÇ ½Ã³ÊÁö È¿°ú, Ŭ¸° ¶óº§ÀÇ µ¿ÇâÀÌ ½ÃÀå Á¦Ç°À» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

Æ÷½ºÆÄƼµô¼¼¸°Àº Á¦Ç° Á¦ÇüÀÇ Çõ½ÅÀ» ÅëÇØ ¼ÒÇÁÆ®Á©, Ãò¾îºí, ±¸¹ÌÁ©, ºÐ¸» À½·á ¹Í½º µî ´Ù¾çÇÑ ÇüÅ·ΠÁ¦°øµÇ°í ÀÖ½À´Ï´Ù. ÀÎÁö ±â´É ºí·»µå¿¡¼­ PS´Â ¿À¸Þ°¡ 3 Áö¹æ»ê(ƯÈ÷ DHA), ÀºÇàÀÙ, L-Å׾ƴÑ, ºñŸ¹Î B±º°ú °°Àº º¸¿Ï ¼ººÐ°ú °áÇÕÇÏ¿© ½Ã³ÊÁö °æ·Î¸¦ ÅëÇØ ½Å°æÀÎÁö È¿°ú¸¦ ³ôÀÌ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Á¦µéÀº ÀϹÝÀûÀ¸·Î ¿¹¹æÀû °Ç°­ ÁöÇâÀû ¼ÒºñÀÚ¿Í ¼º°ú ÁöÇâÀû °Ç°­ ÁöÇâÀû ¼ÒºñÀÚ ¸ðµÎ¸¦ ´ë»óÀ¸·Î ÇÏ´Â '³ú Ȱ¼ºÈ­' ¶Ç´Â 'Á¤½Å°Ç°­' Á¦Ç° ¶óÀο¡ ¼ÓÇÕ´Ï´Ù.

Ŭ¸° ¶óº§ Æ÷Áö¼Å´×°ú ¾Ë·¹¸£°Õ ÇÁ¸® ¼Ò½ÌÀº ÇʼöÀûÀÎ Á¦Ç° ¼Ó¼ºÀÌ µÇ°í ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº À¯ÀüÀÚ º¯Çü ¼ººÐ ¹«ÇÔÀ¯, Äá ¹«ÇÔÀ¯, ±Û·çÅÙ ¹«ÇÔÀ¯, ÇØ¹Ù¶ó±â ·¹½ÃƾÀ» ÇÔÀ¯ÇÑ ºñ°Ç(¿ÏÀü ä½ÄÁÖÀÇÀÚ) Á¦Ç°À» Á¦°øÇÔÀ¸·Î½á ¼ÒºñÀÚÀÇ ±âÈ£¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚÃþ¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í, ½ÄÀÌ Á¦ÇÑÀÌ ÀÖ´Â »ç¶÷µéÀÇ ÁøÀÔÀ庮ÀÌ Á¦°ÅµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¶´ÞÀÇ Åõ¸í¼º°ú Á¦3ÀÚ ÀÎÁõ(NSF, USP, Informed-Choice µî)Àº °æÀïÀÌ Ä¡¿­ÇÑ º¸ÃæÁ¦ ½ÃÀå¿¡¼­ Â÷º°È­¸¦ ²ÒÇÏ´Â µ¥ ÀÖÀ¸¸ç, Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù.

ÀÓ»ó °ËÁõ, ±ÔÁ¦ »óÅÂ, ±â´É¼º ½ÄǰÀÇ ÅëÇÕÀÌ ½ÃÀå ¹üÀ§¸¦ È®´ëÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Æ÷½ºÆÄƼµô¼¼¸°Àº ƯÈ÷ ³ëÈ­¿¡ µû¸¥ ÀÎÁö ±â´É ÀúÇÏ ¹× ½ºÆ®·¹½º »óȲ¿¡¼­ Á¤½Å ´É·Â°ú °ü·ÃÇÏ¿© °­·ÂÇÑ ÀÓ»óÀû ±Ù°Å¸¦ È®º¸Çϰí ÀÖÀ¸¸ç, ¸ÅÀÏ PS¸¦ º¸ÃæÇÏ¸é ¾ð¾îÀû ±â¾ï·ÂÀÌ Çâ»óµÇ°í, ÄÚÆ¼¼Ö À¯¹ß ½ºÆ®·¹½º ÁöÇ¥°¡ °¨¼ÒÇϸç, ³úÀÇ Æ÷µµ´ç ´ë»ç°¡ °Ç°­ÇÏ°Ô À¯ÁöµÈ´Ù´Â ¿¬±¸ °á°ú°¡ ÀÖ½À´Ï´Ù. ³úÀÇ Æ÷µµ´ç ´ë»ç°¡ °Ç°­ÇÏ°Ô À¯ÁöµÇ´Â °ÍÀ¸·Î ¿¬±¸ °á°ú ¹àÇôÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ¿¬±¸ °á°ú´Â ƯÈ÷ ¹Ì±¹¿¡¼­ FDA°¡ ³ëÀÎÀÇ ÀÎÁö ±â´É Àå¾Ö À§Çè °¨¼Ò¿¡ ´ëÇÑ Àû°Ý¼ºÀ» ÀÎÁ¤ÇÏ¿© ±Ù°Å¿¡ ±â¹ÝÇÑ °Ç°­ È¿´ÉÀ» ÁÖÀåÇÒ ¼ö ÀÖ´Â ±Ù°Å°¡ µÇ°í ÀÖ½À´Ï´Ù.

±â´É¼º ½Äǰ ¹× À½·á Á¦Á¶¾÷üµéÀº ÀÏ»óÀûÀ¸·Î ÀÎÁö ±â´ÉÀ» Çâ»ó½Ã۰íÀÚ ÇÏ´Â ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ¹Ù·Î ¸¶½Ç ¼ö ÀÖ´Â ºê·¹ÀÎ °­ÀåÁ¦, °­È­ À¯Á¦Ç°, ¿µ¾ç ¹Ù µî¿¡ PS¸¦ ÷°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦Ç°¿¡ Æ÷½ºÆÄƼµô¼¼¸°ÀÇ ¹èÇÕÀº À¯È­ ½Ã½ºÅÛ°úÀÇ È£È¯¼º ¹× °¡°ø Á¶°Ç¿¡¼­ ¾ÈÁ¤¼ºÀ» À¯ÁöÇÏ´Â ´É·Â¿¡ ÀÇÇØ Áö¿øµË´Ï´Ù. ÀÌ´Â º¸ÃæÁ¦¿¡¼­ ÁÖ·ù ½Äǰ ¹× À½·á ä³Î·ÎÀÇ Å©·Î½º¿À¹ö ¼Ò±¸¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀåÀÇ ¼¼°è ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

Æ÷½ºÆÄƼµô¼¼¸° ½ÃÀåÀÇ ¼ºÀåÀº ÀÎÁö °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, µÎ³ú¸¦ Ȱ¼ºÈ­ÇÏ´Â ¿µ¾ç º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡, ÀÓ»ó ¿¬±¸ Áö¿ø µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÀÌ¿¡ µû¸¥ °æµµÀÎÁöÀå¾Ö ¹× Á¶±â ¾ËÃ÷ÇÏÀ̸Ӻ´°ú °°Àº Áõ»ó Áõ°¡À̸ç, Æ÷½ºÆÄƼµô¼¼¸°Àº ºñħ½ÀÀûÀ̰í Áõ°Å¿¡ ±â¹ÝÇÑ ÁßÀ縦 Á¦°øÇÕ´Ï´Ù.

µ¿½Ã¿¡ ÀþÀº ¼ÒºñÀÚµé »çÀÌ¿¡¼­ »ýȰ½À°üÀ¸·Î ÀÎÇÑ Á¤½ÅÀû ÇǷηΠÀÎÇØ õ¿¬ ÇâÁ¤½Å¼º ÀǾàǰ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, PS´Â Á¤½ÅÀû ¼º°ú ¹× ½ºÆ®·¹½º °ü¸® ¼Ö·ç¼ÇÀÇ ÇÙ½É ¼ººÐÀ¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ±â´É¼º ½Äǰ, Ŭ¸° ¶óº§ º¸ÃæÁ¦, °Ç°­ ÁöÇâÀû À½·á¿¡ ´ëÇÑ Æ÷½ºÆÄƼµô¼¼¸°ÀÇ Àû¿ëÀÌ È®´ëµÊ¿¡ µû¶ó Æ÷½ºÆÄƼµô¼¼¸°ÀÇ »ç¿ëÀº Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ÀÎÁö °Ç°­ R&D¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, Á¦Ç° ÇüÅÂÀÇ ´Ù¾çÈ­´Â ¼º¼÷Ãþ°ú ½ÅÈï °Ç°­ ÁöÇâÃþ ¸ðµÎ¿¡¼­ ½ÃÀåÀÇ Áö¼ÓÀûÀΠħÅõ¸¦ º¸ÀåÇÒ °ÍÀÔ´Ï´Ù.

ºÎ¹®

°ø±Þ¿ø(À°·ù, ¾î·ù, ½Ä¹°), ¼ºÁú(À¯±â, ±âÁ¸), ÇüÅÂ(ºÐ¸», ¾×ü, ĸ½¶), ¿ëµµ(±â´É¼º ½Äǰ, ÀÇ·á ½Äǰ, ½ÄÀ̺¸ÃæÁ¦, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 34°Ç)

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ÀÎÀ§ÀûÀÎ ¼öÀÔ¿ø°¡ Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Global Industry Analysts´Â ¼¼°è ÁÖ¿ä ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ®(1,4,949¸í), ½ÌÅ©ÅÊÅ©(62°³ ±â°ü), ¹«¿ª ¹× »ê¾÷ ´Üü(171°³ ±â°ü)ÀÇ Àü¹®°¡µéÀÇ ÀǰßÀ» ¸é¹ÐÈ÷ °ËÅäÇÏ¿© »ýŰ迡 ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ°í »õ·Î¿î ½ÃÀå Çö½Ç¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¸ðµç ÁÖ¿ä ±¹°¡ÀÇ Àü¹®°¡¿Í °æÁ¦ÇÐÀÚµéÀÌ °ü¼¼¿Í ±×°ÍÀÌ ÀÚ±¹¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇÑ ÀǰßÀ» ÃßÀû Á¶»çÇß½À´Ï´Ù.

Global Industry Analysts´Â ÀÌ·¯ÇÑ È¥¶õÀÌ ÇâÈÄ 2-3°³¿ù ³»¿¡ ¸¶¹«¸®µÇ°í »õ·Î¿î ¼¼°è Áú¼­°¡ º¸´Ù ¸íÈ®ÇÏ°Ô È®¸³µÉ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖÀ¸¸ç, Global Industry Analysts´Â ÀÌ·¯ÇÑ »óȲÀ» ½Ç½Ã°£À¸·Î ÃßÀûÇϰí ÀÖ½À´Ï´Ù.

2025³â 4¿ù: Çù»ó ´Ü°è

À̹ø 4¿ù º¸°í¼­¿¡¼­´Â °ü¼¼°¡ ¼¼°è ½ÃÀå Àüü¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú Áö¿ªº° ½ÃÀå Á¶Á¤¿¡ ´ëÇØ ¼Ò°³ÇÕ´Ï´Ù. ´ç»çÀÇ ¿¹ÃøÀº °ú°Å µ¥ÀÌÅÍ¿Í ÁøÈ­ÇÏ´Â ½ÃÀå ¿µÇâ¿äÀÎÀ» ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.

2025³â 7¿ù: ÃÖÁ¾ °ü¼¼ Àç¼³Á¤

°í°´´Ôµé²²´Â °¢ ±¹°¡º° ÃÖÁ¾ ¸®¼ÂÀÌ ¹ßÇ¥µÈ ÈÄ 7¿ù¿¡ ¹«·á ¾÷µ¥ÀÌÆ® ¹öÀüÀ» Á¦°øÇØ µå¸³´Ï´Ù. ÃÖÁ¾ ¾÷µ¥ÀÌÆ® ¹öÀü¿¡´Â ¸íÈ®ÇÏ°Ô Á¤ÀÇµÈ °ü¼¼ ¿µÇ⠺м®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

»óÈ£ ¹× ¾çÀÚ °£ ¹«¿ª°ú °ü¼¼ÀÇ ¿µÇ⠺м® :

¹Ì±¹ <gt; Áß±¹ <gt; ¸ß½ÃÄÚ <gt; ij³ª´Ù <gt;EU <gt; ÀϺ» <gt; Àεµ <gt; ±âŸ 176°³±¹

¾÷°è ÃÖ°íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®: Global Industry AnalystsÀÇ Áö½Ä ±â¹ÝÀº ±¹°¡, ½ÌÅ©ÅÊÅ©, ¹«¿ª ¹× »ê¾÷ ´Üü, ´ë±â¾÷, ±×¸®°í ¼¼°è °è·® °æÁ¦ »óȲÀÇ Àü·Ê ¾ø´Â ÆÐ·¯´ÙÀÓ ÀüȯÀÇ ¿µÇâÀ» °øÀ¯ÇÏ´Â ºÐ¾ßº° Àü¹®°¡ µî °¡Àå ¿µÇâ·Â ÀÖ´Â ¼ö¼® ÀÌÄÚ³ë¹Ì½ºÆ® ±×·ìÀ» Æ÷ÇÔÇÑ 14,949¸íÀÇ ÀÌÄÚ³ë¹Ì½ºÆ®¸¦ ÃßÀûÇϰí ÀÖ½À´Ï´Ù. 16,491°³ ÀÌ»óÀÇ º¸°í¼­ ´ëºÎºÐ¿¡ ¸¶ÀϽºÅæ¿¡ ±â¹ÝÇÑ 2´Ü°è Ãâ½Ã ÀÏÁ¤À» Àû¿ëÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Phosphatidylserine Market to Reach US$196.9 Million by 2030

The global market for Phosphatidylserine estimated at US$153.5 Million in the year 2024, is expected to reach US$196.9 Million by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Meat Source, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$125.2 Million by the end of the analysis period. Growth in the Fish Source segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$41.8 Million While China is Forecast to Grow at 7.7% CAGR

The Phosphatidylserine market in the U.S. is estimated at US$41.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$40.3 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phosphatidylserine Market - Key Trends & Drivers Summarized

Why Is Phosphatidylserine Gaining Prominence as a Cognitive Health Ingredient?

Phosphatidylserine (PS), a naturally occurring phospholipid primarily found in cell membranes, is experiencing a surge in demand due to its well-documented role in maintaining neuronal integrity, supporting cognitive function, and enhancing memory performance. Originally derived from bovine brain tissue, modern PS supplements are predominantly sourced from soy lecithin or sunflower lecithin, offering a safer and plant-based alternative for consumer use. The increasing prevalence of cognitive decline, attention disorders, and stress-related neurological conditions is driving heightened consumer interest in PS-based products.

Scientific studies have demonstrated phosphatidylserine’s potential in supporting memory retention, improving attention span, and reducing symptoms of cognitive fatigue-especially in aging populations and individuals with attention-deficit challenges. As a result, PS is gaining traction as a key functional ingredient in dietary supplements, nootropic stacks, and functional foods targeting brain health. The compound is particularly popular among seniors, students, athletes, and working professionals seeking mental clarity, focus, and neuroprotection through non-pharmacological means.

How Are Delivery Formats, Ingredient Synergies, and Clean Label Trends Shaping Market Offerings?

Product formulation innovation is expanding phosphatidylserine’s reach across diverse delivery formats including softgels, chewables, gummies, and powdered drink mixes. In cognitive performance blends, PS is increasingly paired with complementary ingredients such as omega-3 fatty acids (especially DHA), ginkgo biloba, L-theanine, and B-complex vitamins to enhance neurocognitive benefits through synergistic pathways. These formulations are commonly positioned in “brain-boosting” or “mental wellness” product lines aimed at both preventive and performance-driven health consumers.

Clean-label positioning and allergen-free sourcing are becoming essential product attributes. Manufacturers are responding to consumer preferences by offering non-GMO, soy-free, gluten-free, and vegan phosphatidylserine formulations derived from sunflower lecithin. This is widening accessibility to health-conscious segments and removing barriers to entry for individuals with dietary restrictions. Additionally, transparency in sourcing and third-party certifications (such as NSF, USP, and Informed-Choice) are gaining importance for differentiation in a crowded and competitive supplements market.

Why Are Clinical Validation, Regulatory Status, and Functional Food Integration Expanding Market Reach?

Phosphatidylserine has earned a strong base of clinical validation, particularly in relation to age-related cognitive decline and mental performance under stress. Studies have shown that daily supplementation of PS can improve verbal recall, reduce cortisol-induced stress markers, and maintain healthy brain glucose metabolism. These findings are enabling evidence-based health claims, especially in the U.S. where the FDA permits qualified claims related to reduced risk of cognitive dysfunction in older adults.

Functional food and beverage manufacturers are increasingly incorporating PS into ready-to-drink brain tonics, fortified dairy products, and nootropic bars, capitalizing on the growing consumer preference for cognitive health in everyday consumption. The inclusion of phosphatidylserine in these products is supported by its compatibility with emulsification systems and its ability to retain stability under processing conditions. This is contributing to its crossover appeal from supplements to mainstream food and beverage channels.

What’s Driving the Global Growth of the Phosphatidylserine Market?

The growth in the phosphatidylserine market is driven by several factors including the rise in cognitive wellness awareness, increasing consumer demand for brain-boosting nutraceuticals, and supportive clinical research. A key growth driver is the aging global population and the associated rise in conditions such as mild cognitive impairment and early-stage Alzheimer’s disease, for which phosphatidylserine offers a non-invasive, evidence-backed intervention.

Simultaneously, lifestyle-induced mental fatigue among younger consumers is driving interest in natural nootropics, positioning PS as a cornerstone ingredient in mental performance and stress management solutions. With growing incorporation into functional foods, clean-label supplements, and health-focused beverages, phosphatidylserine is poised for continued expansion. Regulatory acceptance, rising investments in cognitive health R&D, and diversification of product formats will ensure sustained market penetration across both mature and emerging health-conscious demographics.

SCOPE OF STUDY:

The report analyzes the Phosphatidylserine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Source (Meat, Fish, Plants); Nature (Organic, Conventional); Form (Powder, Liquid, Capsule); Application (Functional Food, Medical Food, Dietary Supplements, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â